prolaio eVO2peak Module vs 1CMR Pro
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if you need to longitudinally estimate peak oxygen consumption (eVO2peak) using real-world patient data from qualified third-party FDA-cleared wearable medical sensors. This cloud-based tool is ideal for cardiovascular research and ongoing patient care, enabling continuous, non-invasive assessment of cardiovascular fitness and risk outside of a traditional clinical setting.
View prolaio eVO2peak Module →Choose 1CMR Pro if…
Choose 1CMR Pro if your primary need is to enhance the speed, accuracy, and precision of Cardiac MRI reporting within a clinical radiology setting. This on-premise AI-enhanced software is best for automating volumetric and functional measurements, ensuring regulatory-grade reproducibility and achieving up to 40% higher precision than manual analysis, all while processing patient data locally within your institution.
View 1CMR Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | 1CMR Pro |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (software-only, processes remote sensor data) | On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
prolaio eVO2peak ModuleTool A, with its cloud-based deployment, generally offers easier setup, broader accessibility, and reduced local IT maintenance for end-users. While Tool B provides a secure web-based platform, its on-premise installation requires more significant initial IT involvement from the user's institution.
Clinical Value
1CMR ProTool B offers a more direct and quantifiable clinical improvement by delivering up to 40% more precise measurements and enabling faster, more consistent cardiac MRI analysis for a critical diagnostic modality. Tool A provides an estimation as an adjunctive aid, which is valuable for longitudinal tracking but perhaps less impactful on immediate diagnostic precision compared to Tool B's claims.
Pricing & Value
TieBoth tools require direct contact for pricing, which is typical for enterprise healthcare software, making a direct cost comparison impossible. Without transparent pricing, it is not feasible to definitively determine which offers superior value for money.
Enterprise Readiness
prolaio eVO2peak ModuleTool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), providing clear assurances for handling protected health information. While Tool B's on-premise deployment and ISO 27001 certification are strong, the lack of explicit HIPAA and BAA statements for the product itself introduces a slight ambiguity for large enterprises.
Innovation
1CMR ProTool B demonstrates significant innovation by applying advanced convolutional neural networks, trained on extensive datasets, to automate and substantially enhance the precision and consistency of complex Cardiac MRI analysis. Tool A's use of deep learning for eVO2peak estimation from wearable data is innovative, but Tool B's impact on a critical diagnostic workflow with quantifiable precision improvements stands out.
Support & Docs
TieNeither the provided structured facts nor web searches yielded specific information regarding the support offerings, documentation quality, or customer service for either tool. Therefore, it is not possible to distinguish between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | 1CMR Pro |
|---|---|---|
| Name | prolaio eVO2peak Module | 1CMR Pro |
| Company | Prolaio | Mycardium AI Limited |
| Primary Function | Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care. | AI-enhanced Cardiac MRI reporting software that delivers more precise measurements for faster and more consistent cardiac MRI analysis. |
| Key Data Inputs/Processing | Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. Applies a locked deep-learning model. | AI-enhanced Cardiac MRI Reporting, automated volumetric and functional measurements. Processes data locally (no patient data transmitted beyond institution). |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and 1CMR Pro.